Quick Answer
Cordyceps Sunshine Biotech Holdings Co., Ltd. reported Cash And Cash Equivalents At Carrying Value of $37.3 thousand for the year ending 2024.
- Cordyceps Sunshine Biotech Holdings Co., Ltd. showed an increase of +61.4% in Cash And Cash Equivalents At Carrying Value from 2023 to 2024.
- This data is from Cordyceps Sunshine Biotech Holdings Co., Ltd.'s annual report (Form 10-K), filed with the SEC on June 13, 2025.
- XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2020 to 2024), Cordyceps Sunshine Biotech Holdings Co., Ltd.'s Cash And Cash Equivalents At Carrying Value has grown by 12,581.6%.
- Historical annual values: Fiscal year 2024: $37.3 thousand | Fiscal year 2023: $23.1 thousand | Fiscal year 2022: $6.6 thousand | Fiscal year 2021: $99.7 thousand | Fiscal year 2020: $294.00.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: